遗传性发育性和癫痫性脑病患者的运动障碍
该国际队列研究对77例遗传性发育性和癫痫性脑病(DEE)患者进行运动障碍(MD)分类,发现刻板动作(37/77,48%)和肌张力障碍(34/77,44%)最常见,47%患者存在多种MD组合;肌张力障碍更常见于不能行走患者,通道病或突触囊泡运输缺陷者更易出现肌张力障碍,刻板动作多见于转录缺陷者。作者认为MD在遗传性DEE中常被低估,识别MD对管理这些复杂神经系统疾病至关重要。
要点
- 刻板动作(48%)和肌张力障碍(44%)是遗传性DEE患者最常见的运动障碍。
- 47%患者存在多种运动障碍组合,中位首次观察年龄为18个月。
- 通道病或突触囊泡运输缺陷者更易出现肌张力障碍,转录缺陷者刻板动作最多见。
核心结论
- 运动障碍在遗传性DEE患者中常被低估,但识别运动障碍对管理这些复杂神经系统疾病至关重要。
- 区分运动障碍与癫痫发作对制定个体化治疗很重要。
- 了解不同生物学机制下出现的运动障碍有助于早期诊断和管理。
研究设计与样本
- 国际队列研究,纳入77例遗传性DEE患者,中位年龄9岁(范围1-38岁)。
- 对运动障碍类型进行分类,并分析特定运动障碍模式是否反映潜在生物学功能障碍。
主要发现
- 刻板动作37/77(48%)和肌张力障碍34/77(44%)最常见,其次为舞蹈症18/77(23%)、肌阵挛14/77(18%)、共济失调9/77(12%)、震颤7/77(9%)和运动减少6/77(8%)。
- 47%患者存在多种运动障碍组合,运动障碍中位首次观察年龄为18个月(范围第2天至35岁)。
- 肌张力障碍更常见于不能行走的患者,而共济失调较少见于不能行走患者。
- 46%患者启动药物治疗(34/77,44%)、深部脑刺激(1/77,1%)或鞘内巴氯芬(1/77,1%)。
- 通道病或突触囊泡运输缺陷患者更易出现肌张力障碍,而刻板动作在转录缺陷个体中最常见。
临床怎么用
- 作者认为识别运动障碍对管理遗传性DEE这类复杂神经系统疾病至关重要。
- 作者认为区分运动障碍与癫痫发作对制定个体化治疗很重要。
- 作者认为了解不同生物学机制下出现的运动障碍有助于早期诊断和管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Movement disorders (MDs) are underrecognized in the developmental and epileptic encephalopathies (DEEs). There are now more than 800 genes implicated in causing the DEEs; relatively few of these rare genetic diseases are known to be associated with MDs. We identified patients with genetic DEEs who had MDs, classified the nature of their MDs, and asked whether specific patterns correlated with the underlying mechanism. METHODS: We classified the type of MDs associated with specific genetic DEEs in a large international cohort of patients and analyzed whether specific patterns of MDs reflected the underlying biological dysfunction. RESULTS: Our cohort comprised 77 patients with a genetic DEE with a median age of 9 (range 1-38) years. Stereotypies (37/77, 48%) and dystonia (34/77, 44%) were the most frequent MDs, followed by chorea (18/77, 23%), myoclonus (14/77, 18%), ataxia (9/77, 12%), tremor (7/77, 9%), and hypokinesia (6/77, 8%). In 47% of patients, a combination of MDs was seen. The MDs were first observed at a median age of 18 months (range day 2-35 years). Dystonia was more likely to be observed in nonambulatory patients, while ataxia was less likely. In 46% of patients, therapy was initiated with medication (34/77, 44%), deep brain stimulation (1/77, 1%), or intrathecal baclofen (1/77, 1%). We found that patients with channelopathies or synaptic vesicle trafficking defects were more likely to experience dystonia; whereas, stereotypies were most frequent in individuals with transcriptional defects. DISCUSSION: MDs are often underrecognized in patients with genetic DEEs, but recognition is critical for the management of these complex neurologic diseases. Distinguishing MDs from epileptic seizures is important in tailoring patient treatment. Understanding which MDs occur with different biological mechanisms will inform early diagnosis and management.
引用
- van der Veen S, Tse GTW, Ferretti A, et al. Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies. Neurology. 2023. PMID: 37748886. doi:10.1212/WNL.0000000000207808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。